| __timestamp | Takeda Pharmaceutical Company Limited | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 520990000000 | 570979 |
| Thursday, January 1, 2015 | 535405000000 | 2185000 |
| Friday, January 1, 2016 | 558755000000 | 4554000 |
| Sunday, January 1, 2017 | 495921000000 | 3605000 |
| Monday, January 1, 2018 | 659690000000 | 5527000 |
| Tuesday, January 1, 2019 | 1089764000000 | 5234000 |
| Wednesday, January 1, 2020 | 994308000000 | 6126000 |
| Friday, January 1, 2021 | 1106846000000 | 6784000 |
| Saturday, January 1, 2022 | 1244072000000 | 7592000 |
| Sunday, January 1, 2023 | 1431505000000 | 11450000 |
| Monday, January 1, 2024 | 1431505000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical landscape, understanding cost dynamics is crucial. Takeda Pharmaceutical Company Limited, a global leader, has seen its cost of revenue soar by approximately 175% from 2014 to 2023. This growth reflects its expansive operations and strategic acquisitions. In contrast, Travere Therapeutics, Inc., a niche player, has experienced a more modest increase of around 1,900% over the same period, albeit from a much smaller base. This stark difference highlights the diverse strategies and market positions of these companies. While Takeda's costs are in the trillions, Travere's remain in the millions, underscoring the scale disparity. Notably, data for 2024 is incomplete, suggesting potential shifts in the coming year. As the pharmaceutical industry continues to innovate, these trends offer a glimpse into the financial strategies shaping the future.
Comparing Cost of Revenue Efficiency: Novo Nordisk A/S vs Takeda Pharmaceutical Company Limited
Cost of Revenue Comparison: Zoetis Inc. vs Travere Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Takeda Pharmaceutical Company Limited vs Ionis Pharmaceuticals, Inc.
Cost of Revenue Comparison: Takeda Pharmaceutical Company Limited vs Xenon Pharmaceuticals Inc.
Cost Insights: Breaking Down Takeda Pharmaceutical Company Limited and HUTCHMED (China) Limited's Expenses
Comparing Cost of Revenue Efficiency: Takeda Pharmaceutical Company Limited vs Mesoblast Limited
Annual Revenue Comparison: Takeda Pharmaceutical Company Limited vs Travere Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Takeda Pharmaceutical Company Limited vs Xencor, Inc.
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs BioCryst Pharmaceuticals, Inc.
Lantheus Holdings, Inc. vs Travere Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cytokinetics, Incorporated vs Travere Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: CRISPR Therapeutics AG vs Travere Therapeutics, Inc.